5063-Palam, Lakshmi Reddy

Lakshmi Reddy Palam, MSC, PhD

Assistant Research Professor of Pediatrics

Joseph E. Walther Hall
980 W. Walnut St.

Indianapolis , IN 46202
Pubmed Logo


Dr. Lakshmi Reddy Palam received his bachelor’s degree from Nagarjuna University, India. Dr. Palam subsequently completed his master’s degree in Biotechnology from Bharathidasan University, India. Dr. Palam completed his Ph.D. degree in biochemistry and molecular biology from Biochemistry department in IU School of Medicine, Indianapolis. Dr. Palam received his research training in laboratory of Dr. Ronald Wek, where he studied mRNA translation regulation mechanisms involved in cellular integrated stress response (ISR). Dr. Palam further pursued postdoctoral fellowship in endocrinology division, medicine department, IU School of Medicine, Indianapolis, where he studied the role of ISR to drug resistance in pancreatic cancer. Dr. Palam is currently the Assistant Research Professor in Herman B Wells Center for Pediatric Research, Pediatrics department, IU School of Medicine.



Titles & Appointments

  • Assistant Research Professor of Pediatrics
  • Education
    2012 FEL Postdoctoral Fellowship, Indiana University School of Medicine
    2012 PhD Indiana University
    2002 MSC Bharathidasan University
    2000 BSC Andhra Loyola College
  • Research

    Dr. Palam research interests include elucidating role of epigenetic factors and cooperating c-KIT mutations in myeloid malignancies. Briefly, epigenetic factors such as TET2, DNMT3a, and ASXL1 are shown to be frequently mutated in myeloid malignancies such as myeloproliferative neoplasms (MPN), acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). Epigenetic alterations in hematopoietic stem and progenitor cells were shown to cause myeloid skewing and results in myeloid malignancies. Dr. Palam’s recent findings that loss of Tet2, a key regulator of genomic DNA methylation content, causes hyper proliferation of myeloid derived mast cells via aberrant activation of PI3K signaling and accumulated oncogenic c-Myc protein. Dr. Palam interested in mechanisms how loss of these epigenetic factors TET2, DNMT3a and ASXL1 drive hematopoietic dysregulation and myeloid malignancies.

  • Professional Organizations
    American Association for Cancer Research
    American Association for the Advancement of Science
    American Society for Biochemistry and Molecular Biology

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor